SE

Carol-Gustaf Goelander

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carol-Gustaf Goelander. Retrieved from https://idiyas.com/inventor/carol-gustaf-goelander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Carol-Gustaf Goelander: Innovator in Oxalate Degradation

Introduction

Carol-Gustaf Goelander is a notable inventor based in Sweden. He has made significant contributions to the field of biochemistry, particularly in the area of oxalate degradation. His work focuses on the purification and isolation of recombinant enzymes that can help reduce oxalate levels in humans.

Latest Patents

Goelander's most recent patent is titled "Purification And Isolation Of Recombinant Oxalate Degrading Enzymes And Spray-Dried Particles Containing Oxalate Degrading Enzymes." This invention comprises methods and compositions aimed at reducing oxalate in humans. It also includes methods for the purification and isolation of recombinant oxalate-reducing enzyme proteins. The invention provides innovative methods and compositions for delivering oxalate-reducing enzymes in particle compositions. These compositions are suitable for treating or preventing oxalate-related conditions.

Career Highlights

Goelander is associated with Oxthera Intellectual Property Ab, where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various health conditions related to oxalate.

Collaborations

He has collaborated with notable colleagues, including Harmeet Sidhu and Qingshan Li, to further enhance the research in this specialized field.

Conclusion

Carol-Gustaf Goelander's innovative work in the purification and isolation of oxalate-degrading enzymes represents a significant advancement in biochemistry. His contributions may lead to improved treatments for oxalate-related health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…